Tempest Therapeutics, Inc. Interest and Dividends Payable, Current
Tempest Therapeutics, Inc. (TPST) had Interest and Dividends Payable, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestAndDividendsPayableCurrent · last filed 2026-03-30
- 2025-12-31: Interest and Dividends Payable, Current $0.00.
- 2025-09-30: Interest and Dividends Payable, Current $0.00.
- 2025-06-30: Interest and Dividends Payable, Current $0.00.
- 2025-03-31: Interest and Dividends Payable, Current $36.00K.
| Period end | Interest and Dividends Payable, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 |
| 2025-03-31 | $36.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $59.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $83.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $106.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $110.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $113.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $106.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $105.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $104.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $97.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $119.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $101.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $94.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $92.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $89.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $89.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $92.00K 10-Q · filed 2022-05-13 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |